NewYork-Presbyterian has adopted Signal 1’s AI Management System (AIMS) to govern and monitor artificial intelligence tools deployed across the New York City-based health system.
The platform will oversee AI technologies ranging from cancer and structural heart disease detection tools to applications supporting discharge planning and clinical documentation, according to an Aug. 3 news release. NewYork-Presbyterian worked closely with Signal 1 to design the platform and establish best practices for responsible AI management in healthcare.
AIMS builds on NewYork-Presbyterian’s existing governance framework, which the health system uses to evaluate AI for safety, performance and accountability. The platform adds a centralized system for managing predictive AI, generative AI and emerging AI agents, with standardized risk assessment, continuous monitoring, bias detection and audit capabilities.
The move reflects a broader shift among health systems, which are increasingly managing AI as a single portfolio rather than evaluating each new tool on its own.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
